Ethylestrenol
![]()  | |
| Systematic (IUPAC) name | |
|---|---|
| 
 (8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl- 2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro- 1H-cyclopenta[a]phenanthren-17-ol  | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names | 
| Legal status | 
  | 
| Identifiers | |
| CAS Number | 
965-90-2  | 
| ATC code | A14AB02 (WHO) | 
| PubChem | CID 13765 | 
| IUPHAR/BPS | 6948 | 
| DrugBank | 
DB01493  | 
| ChemSpider | 
13168  | 
| UNII | 
ADC79EK5Q8  | 
| KEGG | 
D01414  | 
| ChEBI | 
CHEBI:31578  | 
| ChEMBL | 
CHEMBL1200623  | 
| Chemical data | |
| Formula | C20H32O | 
| Molar mass | 288.467 g/mol | 
  | |
  | |
|   | |
Ethylestrenol (brand names Maxibolin, Orabolin), also known as 17α-ethylestr-4-en-17β-ol, is an anabolic steroid with some progestogenic activity, and little androgenic activity. It is a nandrolone derivative and lacks the 3-keto functional group. It was approved in 1964 for testosterone deficiency in male patients.[1]
See also
- Nandrolone (17β-hydroxyestra-4-en-3-one)
 - Ethisterone (17α-ethynyl-17β-hydroxyandrost-4-en-3-one)
 
References
  | ||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
